Cardiovascular Agents

Displaying 1 - 4 of 4CSV
Parikh, S. A., Schneider, P. A., Mullin, C. M., Rogers, T., & Gray, W. A. (2023). Mortality in randomised controlled trials using paclitaxel-coated devices for femoropopliteal interventional procedures: an updated patient-level meta-analysis. The Lancet, 402(10415), 1848–1856. https://doi.org/10.1016/s0140-6736(23)02189-x
Publication Date
Fiuzat, M., Hamo, C. E., Butler, J., Abraham, W. T., DeFilippis, E. M., Fonarow, G. C., Lindenfeld, J., Mentz, R. J., Psotka, M. A., Solomon, S. D., Teerlink, J. R., Vaduganathan, M., Vardeny, O., McMurray, J. J. V., & O’Connor, C. M. (2022). Optimal Background Pharmacological Therapy for Heart Failure Patients in Clinical Trials. Journal of the American College of Cardiology, 79(5), 504–510. https://doi.org/10.1016/j.jacc.2021.11.033
Publication Date